EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of Withania somnifera on cyclophosphamide-induced urotoxicity






Cancer Letters 148(1): 9-17

Effect of Withania somnifera on cyclophosphamide-induced urotoxicity

Administration of an extract from the plant Withania somnifera (Family: Solanaceae) (20 mg/dose/animal; i.p.) for five days along with cyclophosphamide (CTX) (1.5 mmol/kg body wt. i.p.) reduced the CTX induced urotoxicity. Morphological analysis of the bladders of the CTX-treated group showed severe inflammation and dark coloration whereas CTX along with the Withania-treated group showed normal bladder morphology. The extract was found to reduce the protein level in the serum (7.92 g/l) after 4 h of CTX treatment, which was higher in the CTX alone-administered group (11.44 g/l). Blood urea N2 level which was drastically enhanced (136.78 mg/100 ml) 2 after the CTX treatment was significantly reduced (52.08 mg/100 ml) when the animals were treated with Withania extract. Similarly the glutathione (GSH) content in both bladder (1.55 micromol/mg protein) and liver (3.76 micromol/mg protein) was enhanced significantly (P<0.001) in the Withania-treated group compared with the CTX alone-treated animals (bladder 0.5 micromol/mg protein; liver 1.2 micromol/mg protein) Histopathological analysis of the bladder of CTX alone-treated group showed severe necrotic damage where as the Withania somnifera-treated group showed normal bladder architecture.

Accession: 003414482

PMID: 10680587

DOI: 10.1016/s0304-3835(99)00252-9

Download PDF Full Text: Effect of Withania somnifera on cyclophosphamide-induced urotoxicity



Related references

Davis, L.; Kuttan, G., 2000: Effect of Withania somnifera on cyclophosphamide-induced urotoxicity. Administration of an extract from the plant Withania somnifera (Family: Solanaceae) (20 mg/dose/animal; i.p.) for five days along with cyclophosphamide (CTX) (1.5 mmol/kg body wt. i.p.) reduced the CTX induced urotoxicity. Morphological analysis o...

Davis, L.; Kuttan, G., 1998: Suppressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. Administration of Withania somnifera extract (Solanaceae) was found to significantly reduce leucopenia induced by cyclophosphamide (CTX) treatment. The total WBC count on the 12th day of the CTX-treated group was 3720 cells/mm3 and that of CTX alo...

Davis, L.; Kuttan, G., 1999: Effect of Withania somnifera on cytokine production in normal and cyclophosphamide treated mice. Administration of an extract from powdered roots of W. somnifera (obtained from a commercial source in India) enhanced the levels of interferon- gamma (IFN- gamma ) (to 75.87 pg/ml from 40 pg/ml), interleukin-2 (IL-2) (to 14.16 pg/ml from 7.37 pg/...

Mazen E.S.; Pavelescu M.; Grigorescu E., 1990: Contributions to the pharmacodynamic study of roots of withania somnifera dun species of pakistani origin note iii testing of analgesic activity of dichloromethanic and methanolic extract from withania somnifera roots. Revista Medico-Chirurgicala Societatii di Medici si Naturalisti din Iasi 94(3-4): 603-605

Sakka Mazen, E.; Pavelescu, M.; Grigorescu, E., 1990: Contributions to the pharmacodynamic study of roots of Withania somnifera Dun species of Pakistani origin. Note III: Testing of analgesic activity of dichlormethanic and methanolic extract from Withania somnifera roots. Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 94(3-4): 603-605

Davis, L.; Girija Kuttan, 2001: Effect of Withania somnifera on DMBA induced carcinogenesis. Administration of an extract of Withania somnifera was found to reduce two stage skin carcinogenesis induced by DMBA (dimethyl benzanthracene) and croton oil. Withania somnifera was administered at a concentration of (20 mg/dose/animal i.p.) conse...

Davis, L.; Kuttan, G., 2001: Effect of Withania somnifera on DMBA induced carcinogenesis. Administration of an extract of Withania somnifera was found to reduce two stage skin carcinogenesis induced by DMBA (dimethyl benzanthracene) and croton oil. Withania somnifera was administered at a concentration of (20 mg/dose/animal i.p.) conse...

Davis, L.; Kuttan, G., 2000: Effect of Withania somnifera on 20-methylcholanthrene induced fibrosarcoma. Administration of an extract from the root of the plant Withania somnifera (20mg/dose/animal i.p) was found to inhibit the 20-methylcholanthrene induced sarcoma development in mice and increase the life span of tumour bearing animals. Administrati...

Adnan Ayhanci; Ruhi Uyar; Erinc Aral; Selda Kabadere; Sila Appak, 2009: Protective Effect of Zinc on Cyclophosphamide-Induced Hematoxicity and Urotoxicity. Biological Trace Element Research 127(3): 284-284

Ayhanci, A.; Uyar, R.; Aral, E.; Kabadere, S.; Appak, S., 2008: Protective effect of zinc on cyclophosphamide-induced hematoxicity and urotoxicity. Cyclophosphamide (CP) is widely used for the treatment of neoplastic diseases; however, its toxicity causes dose-limiting side effects. Zinc (Zn) is an essential trace element and has important biological functions that control many cell processes...